Literature DB >> 18951294

Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.

Brian J Van Lenten1, Mohamad Navab, G M Anantharamaiah, Georgette M Buga, Srinivasa T Reddy, Alan M Fogelman.   

Abstract

Apolipoprotein mimetic peptides dramatically reduce atherosclerosis in animal models, and may be an excellent mode of therapy to treat a variety of vascular inflammatory conditions, including atherosclerosis. Studies of apolipoprotein mimetic peptides in models of inflammatory disorders other than atherosclerosis, including viral influenza, asthma, chronic rejection after heart transplantation, sickle cell disease, scleroderma, diabetes, cognitive dysfunction and renal inflammation, suggest that apolipoprotein mimetic peptides may have efficacy in a wide range of inflammatory conditions.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18951294      PMCID： PMC2856620     

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN： 1472-4472


  46 in total

Review 1.  Lymphocytes and monocytes in the aortic intima--An electron-microscopic study in the rat.

Authors:  I Joris; E Stetz; G Majno
Journal:  Atherosclerosis       Date:  1979-11       Impact factor: 5.162

2.  LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.

Authors:  Sandra A Schreyer; Cynthia Vick; Theodore C Lystig; Paul Mystkowski; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-01       Impact factor: 4.310

3.  L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.

Authors:  Jingsong Ou; Zhijun Ou; Deron W Jones; Sandra Holzhauer; Ossama A Hatoum; Allan W Ackerman; Dorothee W Weihrauch; David D Gutterman; Karen Guice; Keith T Oldham; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

4.  Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.

Authors:  Michael Yeh; Amy L Cole; Jenny Choi; Yi Liu; Dmitry Tulchinsky; Jian-Hua Qiao; Michael C Fishbein; Alek N Dooley; Talin Hovnanian; Kevin Mouilleseaux; Devendra K Vora; Wen-Pin Yang; Peter Gargalovic; Todd Kirchgessner; John Y-J Shyy; Judith A Berliner
Journal:  Circ Res       Date:  2004-09-23       Impact factor: 17.367

5.  Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine.

Authors:  G M Anantharamaiah; J L Jones; C G Brouillette; C F Schmidt; B H Chung; T A Hughes; A S Bhown; J P Segrest
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

6.  Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.

Authors:  Mohamad Navab; G M Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Victor R Grijalva; Alan C Wagner; Joy S Frank; Geeta Datta; David Garber; Alan M Fogelman
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

7.  Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice.

Authors:  Dorothee Weihrauch; Hao Xu; Yang Shi; Jingli Wang; Jennifer Brien; Deron W Jones; Sushma Kaul; Richard A Komorowski; Mary Ellen Csuka; Keith T Oldham; Kirkwood A Pritchard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-11       Impact factor: 4.733

8.  Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.

Authors:  Jesus A Araujo; Lingzhong Meng; Aaron D Tward; Wayne W Hancock; Yuan Zhai; Annie Lee; Kazunobu Ishikawa; Suhasini Iyer; Roland Buelow; Ronald W Busuttil; Diana M Shih; Aldons J Lusis; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Authors:  Steven E Nissen; Taro Tsunoda; E Murat Tuzcu; Paul Schoenhagen; Christopher J Cooper; Muhammad Yasin; Gregory M Eaton; Michael A Lauer; W Scott Sheldon; Cindy L Grines; Stephen Halpern; Tim Crowe; James C Blankenship; Richard Kerensky
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

10.  Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.

Authors:  Brian J Van Lenten; Alan C Wagner; G M Anantharamaiah; David W Garber; Michael C Fishbein; Lopa Adhikary; Debi P Nayak; Susan Hama; Mohamad Navab; Alan M Fogelman
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690
View more
  17 in total

1.  Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis.

Authors:  Grégoire Ruffenach; Ellen O'Connor; Mylène Vaillancourt; Jason Hong; Nancy Cao; Shervin Sarji; Shayan Moazeni; Jeremy Papesh; Victor Grijalva; Christine M Cunningham; Le Shu; Arnab Chattopadhyay; Shuchita Tiwari; Olaf Mercier; Frédéric Perros; Soban Umar; Xia Yang; Aldrin V Gomes; Alan M Fogelman; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?

Authors:  A T Remaley
Journal:  J Lipid Res       Date:  2013-10-21       Impact factor: 5.922

3.  Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.

Authors:  Yoshihisa Nukui; Yasunari Miyazaki; Kozo Suhara; Tsukasa Okamoto; Haruhiko Furusawa; Naohiko Inase
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

4.  Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.

Authors:  Feng Su; Kathy R Kozak; Satoshi Imaizumi; Feng Gao; Malaika W Amneus; Victor Grijalva; Carey Ng; Alan Wagner; Greg Hough; Gina Farias-Eisner; G M Anantharamaiah; Brian J Van Lenten; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  ApoA-I mimetics: tomatoes to the rescue.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2013-03-07       Impact factor: 5.922

Review 6.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

7.  D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.

Authors:  Ekambaram Ganapathy; Feng Su; David Meriwether; Asokan Devarajan; Victor Grijalva; Feng Gao; Arnab Chattopadhyay; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Int J Cancer       Date:  2011-05-26       Impact factor: 7.396

Review 8.  Structure and function of HDL mimetics.

Authors:  Mohamad Navab; Ishaiahu Shechter; G M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

9.  Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.

Authors:  Salil Sharma; Soban Umar; Francois Potus; Andrea Iorga; Gabriel Wong; David Meriwether; Sandra Breuils-Bonnet; Denise Mai; Kaveh Navab; David Ross; Mohamad Navab; Steeve Provencher; Alan M Fogelman; Sébastien Bonnet; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Circulation       Date:  2014-06-24       Impact factor: 29.690

10.  The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosis.

Authors:  Luke J Leman
Journal:  Clin Lipidol       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.